NFAT5 and neoplasm: Importantly, we noted no difference (Figure 7J) in the tumor localization of injected CD4+T cells (and also localization to other secondary lymphoid organs and solid organs) between lymphocytes obtained from wild-type versus NFAT5-KO mice.